Dermatology Risks Are Likely Different for JAK Inhibitors Dermatology Risks Are Likely Different for JAK Inhibitors

Black box warnings for JAK inhibitors arise from rheumatoid arthritis studies, leading one expert to question the risk-benefit relevance to dermatologic diseases, particularly in younger patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news